financetom
Business
financetom
/
Business
/
German regulator ends probe into Google's in-car services after agreed remedies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
German regulator ends probe into Google's in-car services after agreed remedies
Apr 9, 2025 2:34 AM

BERLIN, April 9 (Reuters) - Germany's Federal Cartel

Office has closed proceedings into Google's automotive services

after the U.S. tech giant committed to remedies addressing its

concerns over competition, the regulator said on Wednesday.

"I am delighted that we have been able to reach an agreement

with Google and thus achieve immediate positive effects for the

economic sectors affected. Google's commitments have the

potential to bring about far-reaching changes in the market,"

cartel office president Andreas Mundt said in a statement.

The office had previously expressed concerns over the

company's in-car maps and infotainment systems due to their

bundled form, which it said could impede competitors' chances of

selling similar services individually.

In December 2023, around six months after the regulator

raised these concerns and a potential ban, Google sought to

dispel them by proposing measures that would allow the use of

competitors' maps and apps within its platform.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alvotech Says European Medicines Agency Has Accepted Marketing Application for AVT06
Alvotech Says European Medicines Agency Has Accepted Marketing Application for AVT06
Aug 15, 2024
05:12 AM EDT, 08/15/2024 (MT Newswires) -- Alvotech ( ALVO ) said Thursday that the European Medicines Agency has accepted a marketing authorization application for AVT06, the company's proposed biosimilar to Eylea. Eylea is a widely used biologic for the treatment of eye disorders, the company said. The approvals process is expected to be completed in Q3 2025. Alvotech (...
Interactive Brokers Expands Overnight Trading Offering With Contracts for Difference
Interactive Brokers Expands Overnight Trading Offering With Contracts for Difference
Aug 15, 2024
05:14 AM EDT, 08/15/2024 (MT Newswires) -- Interactive Brokers ( IBKR ) said Thursday it has expanded its overnight trading offering to include contracts for difference on US stocks and exchange-traded funds. The company said contracts for difference will be offered on over 3,500 US stocks and ETFs during overnight trading hours, from 8 pm ET to 3:50 am ET,...
US expects $6 bln savings from first Medicare drug price negotiations
US expects $6 bln savings from first Medicare drug price negotiations
Aug 15, 2024
WASHINGTON, Aug 15 (Reuters) - The U.S. government will save $6 billion in the first year from lower prices the Biden administration negotiated on 10 top-selling prescription drugs for the Medicare health program for older Americans, officials said on Thursday. President Joe Biden's signature Inflation Reduction Act, signed into law in 2022, allows Medicare to negotiate prices for some of...
Anew Medical Secures US Patent for Gene Therapy for Neurodegenerative, Age-Related Disorders
Anew Medical Secures US Patent for Gene Therapy for Neurodegenerative, Age-Related Disorders
Aug 15, 2024
05:37 AM EDT, 08/15/2024 (MT Newswires) -- Anew Medical ( WENA ) said Thursday it secured a US patent covering an RNA splice variant of human Klotho gene s-KL for the treatment of cognitive and neurodegenerative diseases. The patent follows similar patents issued in Europe, China and other Asian markets, according to the company. The intellectual property portfolio provides the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved